Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 435

1.

Factors associated with psychotic symptoms in Alzheimer's disease.

Hirono N, Mori E, Yasuda M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Hashimoto M, Yamashita H.

J Neurol Neurosurg Psychiatry. 1998 May;64(5):648-52.

2.

Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates.

Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG.

Int J Geriatr Psychiatry. 2000 Feb;15(2):99-107.

PMID:
10679840
3.

[Psychotic symptoms and Alzheimer's disease].

Alberca R, Gil-Néciga E, Salas D, Pérez JA, Lozano P.

Neurologia. 2000 Jan;15(1):8-14. Spanish.

PMID:
10730061
4.

Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings.

Förstl H, Besthorn C, Geiger-Kabisch C, Sattel H, Schreiter-Gasser U.

Acta Psychiatr Scand. 1993 Jun;87(6):395-9.

PMID:
8356890
5.

Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer's disease.

Migliorelli R, Petracca G, Tesón A, Sabe L, Leiguarda R, Starkstein SE.

Psychol Med. 1995 May;25(3):505-13.

PMID:
7480431
6.

Psychotic symptoms and physically aggressive behavior in Alzheimer's disease.

Gilley DW, Wilson RS, Beckett LA, Evans DA.

J Am Geriatr Soc. 1997 Sep;45(9):1074-9.

PMID:
9288014
7.

Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease.

Harwood DG, Barker WW, Ownby RL, St George-Hyslop P, Duara R.

Am J Geriatr Psychiatry. 1999 Spring;7(2):119-23.

PMID:
10322238
8.

The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease.

Lopez OL, Kamboh MI, Becker JT, Kaufer DI, DeKosky ST.

Neurology. 1997 Sep;49(3):794-7. Erratum in: Neurology 1998 Feb;50(2):566.

PMID:
9305342
9.

Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.

O'Meara ES, Kukull WA, Sheppard L, Bowen JD, McCormick WC, Teri L, Pfanschmidt M, Thompson JD, Schellenberg GD, Larson EB.

Am J Epidemiol. 1997 Sep 1;146(5):373-84.

PMID:
9290497
10.

Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease.

Sawada H, Udaka F, Izumi Y, Nishinaka K, Kawakami H, Nakamura S, Kameyama M.

J Neurol Neurosurg Psychiatry. 2000 May;68(5):653-6.

11.

Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype.

Gabryelewicz T, Religa D, Styczynska M, Peplonska B, Pfeffer A, Wasiak B, Luczywek E, Golebiowski M, Androsiuk W, Czyzewski K, Przekop I, Barcikowska M.

Dement Geriatr Cogn Disord. 2002;14(4):208-12.

PMID:
12411763
12.

Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease.

Levy ML, Cummings JL, Fairbanks LA, Sultzer DL, Small GW.

Biol Psychiatry. 1999 Feb 15;45(4):422-5.

PMID:
10071711
13.

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV.

Neurology. 2000 May 23;54(10):1965-71.

PMID:
10822438
14.

The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up.

Ballard CG, O'Brien JT, Swann AG, Thompson P, Neill D, McKeith IG.

J Clin Psychiatry. 2001 Jan;62(1):46-9.

PMID:
11235928
15.

Associations of psychotic symptoms in dementia sufferers.

Ballard C, Bannister C, Graham C, Oyebode F, Wilcock G.

Br J Psychiatry. 1995 Oct;167(4):537-40.

PMID:
8829726
16.

EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease.

Lopez OL, Brenner RP, Becker JT, Ulrich RF, Boller F, DeKosky ST.

Neurology. 1997 Jun;48(6):1521-5.

PMID:
9191759
17.

Memory self-appraisal and depressive symptoms in people at genetic risk for Alzheimer's disease.

Small GW, Chen ST, Komo S, Ercoli L, Miller K, Siddarth P, Kaplan A, Dorsey D, Lavretsky H, Saxena S, Bookheimer SY.

Int J Geriatr Psychiatry. 2001 Nov;16(11):1071-7.

PMID:
11746653
18.

Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease.

Rosen J, Zubenko GS.

Biol Psychiatry. 1991 Feb 1;29(3):224-32.

PMID:
2015329
19.

Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease.

Weiner MF, Vega G, Risser RC, Honig LS, Cullum CM, Crumpacker D, Rosenberg RN.

Biol Psychiatry. 1999 Mar 1;45(5):633-8.

PMID:
10088051
20.

The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.

Paulino Ramirez Diaz S, Gil Gregório P, Manuel Ribera Casado J, Reynish E, Jean Ousset P, Vellas B, Salmon E.

Int J Geriatr Psychiatry. 2005 Aug;20(8):744-8.

PMID:
16035121

Supplemental Content

Support Center